Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease

Circulation

Volumn 96, Issue 12, 1997, Pages 4204-4210

  Toss, H ^a   Lindahl, B ^a   Siegbahn, A ^a   Wallentin, L ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angina; Fibrinogen; Infarction; Mycardial; Prognosis; Risk factors

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; UNSTABLE ANGINA PECTORIS;

EID: 0031454016     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.12.4204     Document Type: Article

References (35)

1. Levenson J, Giral P, Razavian M, Gariepy J, Simon A. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arterioscler Thromb Vasc Biol. 1995;15:1263-1268.
2. Tracy R, Bovil E, Yanez D, Psaty B, Fried L, Heiss G, Lee M, Pollak J, Savage P. Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Arterioscler Thromb Vasc Biol. 1995;15:1269-1279.
3. Meade T, Chakrabarti R, Haines A, North W, Stirling Y, Thomson S. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980;1:1050-1053.
4. Stone M, Thorp J. Plasma fibrinogen: a major coronary risk factor. J R Coll Gen Pract. 1985;35:565-569.
5. Kannel W, Wolf P, Castelli W, D'Agostino R. Fibrinogen and risk of cardiovascular disease. JAMA. 1987;258:1183-1186.
6. Heinrich J, Balleisen L, Schulte H, Assman G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Arterioscler Thromb. 1994;14:54-59.
7. Yarnell J, Baker I, Sweetnam P, Dainton D, O'Brian J, Whitehead P, Elwood P. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. Circulation. 1991;83:836-844.
8. Kostis J, Baughman J, Kuo P. Association of recurrent myocardial infarction with hemostatic factors. Chest. 1982;81:571-575.
9. Burr M, Holliday R, Fehily A, Whitehead P. Haematological prognostic indices after myocardial infarction: evidence from the Diet and Reinfarction Trial (DART). Eur Heart J. 1992;13:166-170.
10. Benderly M, Reicher-Reiss H, Behar S, Brunner D, Goldbourt U. Fibrinogen is a predictor of mortality in coronary heart disease patients. Arterioscler Thromb Vasc Biol. 1996;16:351-356.
11. Saxena K, Gupta B, Gopal R, Srivastave S, Singh R, Kulshrestha V, Prasas D. Plasma fibrinogen and serum enzymes: relative significance as prognostic indicator in acute myocardial infarction. J Assoc Phys India. 1986;34:641-642.
12. Haines A, Howarth D, North W, Goldenberg E, Stirling Y, Meade T, Raferty E, Craig M. Haemostatic variables and the outcome of myocardial infarction. Thromb Haemostas. 1983;50:800-803.
13. Pollak H, Fischer M, Fritsch S, Enenkel W. Are admission plasma fibrinogen levels useful in the characterization of risk groups after myocardial infarction treated with fibrinolysis? Thromb Haemostas. 1991;66:406-409.
14. Cristal N, Slonim A, Bar-Ilan I, Hart A. Plasma fibrinogen levels and the clinical course of acute myocardial infarction. Angiology. 1983;34:693-698.
15. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation. 1985;71:699-708.
16. Arbustini E, Grasso M, Diegoli M, Pucci A, Bramerio M, Ardissino D, Angoli L, de Servi S, Bramucci E, Mussini A, Minzioni G, Vigano M, Specchia G. Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: a morphologic, immunohisto-chemical, and biochemical study. Am J Cardiol. 1991;68:36B-50B.
17. Eastham R, Morgan E. Plasma-fibrinogen levels in coronary-artery disease. Lancet. 1963;2:1196-1197.
18. Kanda T, Hirao Y, Oshima S, Oshima S, Yausa K, Taniguchi K, Nagai R, Kobayashi I. Interleukin-8 is a sensitive marker of unstable coronary artery disease. Am J Cardiol. 1996;77:304-307.
19. Berk B, Weintraub W, Alexander W. Elevation of C-reactive protein in 'active' coronary artery disease. Am J Cardiol. 1990;65:168-172.
20. Liuzzo G, Biasucci L, Gallimore R, Grillo R, Rebuzzi A, Pepys M, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331:417-424.
21. Thompson S, Kienast J, Pyke S, Haverkate F, van de Loo J. Memostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635-641.
22. FRISC Study Group. Low-molecular-weight heparin during instability in coronary artery disease. Lancet. 1996;1:561-568.
23. Gillum RF, Fortman SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction. Am Heart J. 1984;108:150-157.
24. Gerhardt W, Katus H. Ravkilde J, Hamm C. S-Troponin-T as a marker of ischemic myocardial injury. Clin Chem. 1994;38:1194-1195.
25. Wu A, Valdes R, Apple F, Gornel T, Stone M, Mayfield-Stokes S, Ingersoll-Stroubos A, Wiler B. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction. Clin Chem. 1994;40:900-907.
26. Swahn E, von Schenk H, Wallentin L. Plasma fibrinogen in unstable coronary artery disease. Scand J Clin Lab Invest. 1989;49:49-54.
27. Becker R, Cannon C, Bovill E, Tracy R, Thompson B, Knatterud G, Randall A, Braunwald E. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction. Am J Cardiol. 1996;78:142-147.
28. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac event in unstable coronary artery disease. Circulation. 1996;93:1651-1657.
29. van Milternburg-van Zijl A, Simoons M, Veerhoek R, Bossuyt P. Incidence and follow-up of Braunwald subgroups in unstable angina pectoris. J Am Coll Cardiol. 1995;25:1286-1292.
30. Silva J, Escobar A, Collins T, Ramee S, White C. Unstable angina: a comparison of angioscopic findings between diabetic and nondiabetic patients. Circulation. 1995;92:1731-1736.
31. de Feyter P, Ozaki Y, Baptista J, Escaned J, Di Mario C, de Jaegere P, Serruys P, Roelandt J. Ischemia-related lesion characteristics in patients with stable or unstable angina. Circulation. 1995;92:1408-1413.
32. Meade T, Vickers M, Thompson S, Seghatchian M. The effect of physiological levels of fibrinogen on platelet aggregation. Thromb Res. 1985;38:527-534.
33. Chooi C, Gallus A. Acute phase reaction, fibrinogen level and thrombus size. Thromb Res. 1989;53:493-501.
34. Neumann F-J, Katus H, Hoberg E, Roebruck P, Braun M, Haupt H-M, Tillmans H, Kübier W. Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable clinical outcome in patients with unstable angina pectoris. Br Heart J. 1991;66:425-430.
35. The Scandinavian Simvastatin Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet. 1994;344:1383-1389.